These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25252170)

  • 1. Mammary carcinomas with neuroendocrine features--correct understanding and proper use of the terminology.
    Kawasaki T; Sugai T; Kashiwaba M; Sapino A
    Histopathology; 2015 Apr; 66(5):754-5. PubMed ID: 25252170
    [No Abstract]   [Full Text] [Related]  

  • 2. Reclassification of mammary carcinomas with neuroendocrine features in accordance with neuroendocrine morphologies in the revised World Health Organization classification.
    Kwon SY; Bae YK
    Histopathology; 2015 Apr; 66(5):755-6. PubMed ID: 25387765
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors.
    Sica G; Wagner PL; Altorki N; Port J; Lee PC; Vazquez MF; Saqi A
    Arch Pathol Lab Med; 2008 Dec; 132(12):1889-95. PubMed ID: 19061285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine differentiation correlates with hormone receptor expression and decreased survival in patients with invasive breast carcinoma.
    Kwon SY; Bae YK; Gu MJ; Choi JE; Kang SH; Lee SJ; Kim A; Jung HR; Kang SH; Oh HK; Park JY
    Histopathology; 2014 Apr; 64(5):647-59. PubMed ID: 24117859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and progesterone receptor expression in the mammary gland tumors.
    Moise M; Buruian MM; Ilie C; Zamfir CL; Folescu R; Motoc AG
    Rom J Morphol Embryol; 2013; 54(4):961-8. PubMed ID: 24398991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sensitivity and specificity of estrogen receptor, progesterone receptor and HER-2 staining in core biopsies of invasive breast carcinomas.
    Frederik P; Cecile C; Tjalma WA
    Breast J; 2007; 13(4):436-7. PubMed ID: 17593058
    [No Abstract]   [Full Text] [Related]  

  • 7. How to measure and report the estrogen (and progesterone) receptor in breast cancer.
    Vermeulen PB; Van Laere SL; Dirix LY
    Int J Gynecol Cancer; 2006; 16 Suppl 2():529-32. PubMed ID: 17010066
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary neuroendocrine carcinoma of the breast.
    Bergstrom C; Porembka J; Fang Y; Sarode V; Syed S
    Breast J; 2019 May; 25(3):519-520. PubMed ID: 31001910
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple steroid receptors in human breast cancer. II. Estrogen and progestin receptors in 672 primary tumors.
    Martin PM; Rolland PH; Jacquemier J; Rolland AM; Toga M
    Cancer Chemother Pharmacol; 1979; 2(2):107-13. PubMed ID: 535121
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of estrogen and progesterone receptors in cancer of the breast. Frequency of presentation and prognostic significance].
    Expósito J; Olea N; Ruiz de Almodovar JM; Pedraza V
    Rev Esp Oncol; 1985; 32(3):471-85. PubMed ID: 3870538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone receptor-positive breast cancer: the known and the unknown.
    Dawood S; Gonzalez-Angulo AM
    Oncology (Williston Park); 2012 Aug; 26(8):700-1. PubMed ID: 22957402
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship of progesterone-receptor positivity in malignant breast tumors to reproductive status of women at tumor initiation--results from patients with possible radiation-induced tumors.
    Olsson H; Sigurdsson H; Borg A; Fernö M
    J Natl Cancer Inst; 1990 Mar; 82(6):529-31. PubMed ID: 2313726
    [No Abstract]   [Full Text] [Related]  

  • 13. The natural history of hormone receptor-positive breast cancer: attempting to decipher an intriguing concept.
    Nagaraj G; Ellis MJ; Ma CX
    Oncology (Williston Park); 2012 Aug; 26(8):696-7, 700. PubMed ID: 22957401
    [No Abstract]   [Full Text] [Related]  

  • 14. Problems with the progesterone receptor in practice?
    Jordan VC; Gelber RD
    J Clin Oncol; 2007 May; 25(15):1957-9. PubMed ID: 17452674
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
    Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
    Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple-negative breast cancer and brain metastases.
    Sait B; Cinar E; Altundag K
    Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):84. PubMed ID: 19751969
    [No Abstract]   [Full Text] [Related]  

  • 17. Progesterone receptor in estrogen receptor-positive breast cancer: the association between HER-2 and lymph node involvement is age related.
    Neven P; Pochet N; Drijkoningen M; Amant F; De Smet F; Paridaens R; Christiaens MR; Vergote I
    J Clin Oncol; 2006 Jun; 24(16):2595; author reply 2595-7. PubMed ID: 16735717
    [No Abstract]   [Full Text] [Related]  

  • 18. Triple-negative breast cancer.
    Oncology (Williston Park); 2010 Oct; 24(10 Suppl):40a. PubMed ID: 21275325
    [No Abstract]   [Full Text] [Related]  

  • 19. [MicroRNA and breast cancer-related hormone receptors].
    ZHANG J; NIU Y; YU Q
    Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):212-4. PubMed ID: 21575403
    [No Abstract]   [Full Text] [Related]  

  • 20. [Important "reference conditions" in the interpretation of hormone receptor findings in human breast carcinomas. Studies of the nude mouse model].
    Michel RT; Bastert G
    Med Welt; 1983 Mar; 34(12):373-7. PubMed ID: 6855536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.